Solvar books higher profit in H1 FY26
Solvar (ASX:SVR) reported a normalised net profit after tax of $20 million in the first half of FY26, representing a steady 5.8% increase.
Solvar (ASX:SVR) reported a normalised net profit after tax of $20 million in the first half of FY26, representing a steady 5.8% increase.
Capstone Copper (ASX:CSC) outlined a strategic roadmap defined by steady production targets and significant capital investment in its development pipeline.
Marimaca Copper (ASX:MC2) announced a global offering totaling approximately CAD$409 million.
TechnologyOne (ASX:TNE), announced an upgrade to its FY26 financial guidance, citing the transformative impact of its "SaaS+" strategy and artificial intelligence integration.
Vicinity Centres (ASX:VCX) has delivered a 63.5% increase in statutory net profit after tax, reaching $805.6 million, for first half of fiscal year 2026.
The Monetary Policy Committee of the Reserve Bank of New Zealand elected to hold the official cash rate at 2.25%.
Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.
The national wage price index climbed 0.8% in the December quarter of 2025, maintaining a steady annual growth rate of 3.4%.
Magellan Financial (ASX:MFG) logged a robust operating profit after tax of $83.1 million for the first half of FY26.
Hansen Technologies (ASX:HSN) reported a total operating revenue of $191 million for the first half of FY26, representing a 7.3% increase a year earlier.
Netwealth Group (ASX:NWL) has reported a stellar start to the 2026 financial year, underpinned by a 24.7% growth in total income to $193.8 million.
Biotech firm CSL (ASX:CSL) has entered into an exclusive licensing agreement with US pharmaceutical giant Eli Lilly and Company.